DS
David P Schenkein (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $1.9M of DNLI (59,441 sh across 2 lots, as filed), executed Nov 11 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 11 2024
Filed Nov 13 2024
Median ADV $37.0M across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
DNLI
Denali Therapeutics Inc.
DNLI · 0 buys · 1 sell
1 filing
Recent filings
DNLISALE
Denali Therapeutics Inc.
View filing →
$1.9M59,441 sh across 2 lots
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET